Canaccord Genuity reiterated a Buy rating on Allergen (NYSE: AGN), and raised the price target to $396.00 (from $352.00), following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst PT Change Mergers and Acquisitions

Canaccord Genuity Raises Price Target on Teva Pharma (TEVA) Following Announced Acquisition of Allergan Generics July 28, 2015 9:23 AM Leerink Partners Raised Price Target on Allergan (AGN) to $388 Following TEVA Announcement July 28, 2015 8:19 AM Juniper Pharmaceuticals Announces Regulatory Approvals for CRINONE® Progesterone Gel in Nine New EU CountriesJuly 28, 2015 7:00 AM Allergen (AGN) PT Raised to $366 at UBS Following Generic DealJuly 28, 2015 6:57 AM Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan’s Pending Acquisition of KYTHERAJuly 27, 2015 5:45 PM Market Wrap: Chinese Stock Pressure Hits U.S. Markets; Durable Orders Outpace in June; Merger MondayJuly 27, 2015 5:22 PM Allergan (AGN), KYTHERA Biopharma (KYTH) Announce Early HSR Act Termination in Proposed MergerJuly 27, 2015 4:46 PM Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERAJuly 27, 2015 4:45 PM Allergan CEO, fresh off one deal, sets sights on othersJuly 27, 2015 11:52 AM Notable Mergers and Acquisitions 7/27: (TEVA)/(AGN) (WAB) (BECN) (SNY) (XUE)July 27, 2015 9:58 AM Pre-Open Stock Movers 07/27: (MAG) (TEVA) (AGN) Higher; (BLPH) (MYL) (GRUB) Lower (more...)July 27, 2015 9:35 AM VistaGen Therapeutics (VSTA) Highlighted at Chardan Capital After Allergan Acquires Comp NaurexJuly 27, 2015 8:23 AM Wall Street drops as China stock slump stokes growth fearsJuly 27, 2015 7:48 AM Perrigo (PRGO) Gains After Teva (TEVA) Withdraws Proposal to Acquire Mylan (MYL)July 27, 2015 7:25 AM Allergan (AGN) Enters agreement to Acquire Naurex in Net $560M DealJuly 27, 2015 6:48 AM Mylan (MYL) Comments on Teva/Allergan Deal; Strategic Focus Remains UnchangedJuly 27, 2015 6:43 AM Teva Pharma (TEVA) to Acquire Allergan Genetics (AGN) in $40.5B Cash and Stock DealJuly 27, 2015 6:03 AM Allergan Accelerates Transformation to Branded Growth Pharma Leader by Divesting Global Generics Business to Teva for $40.5 BillionJuly 27, 2015 4:37 AM Teva to Acquire Allergan Generics for $40.5 Billion Creating a Transformative Generics and Specialty Company Well Positioned to Win in Global HealthcareJuly 27, 2015 4:30 AM Teva Pharma (TEVA) Nears Deal to Acquire Allergan's (AGN) Generic-Drug BusinessJuly 26, 2015 5:23 PM Allergan to Acquire NaurexJuly 26, 2015 8:00 AM